
    
      Type 1 diabetes mellitus (T1DM)is characterized by the autoimmune destruction of the
      pancreatic β cells.Patients require multiple daily insulin injections throughout their lives
      as well as close monitoring of their diet and blood sugar levels to prevent complications.
      The investigators hope umbilical cord Mesenchymal Stem Cells could not only address the need
      for β-cell replacement but also control of the autoimmune response to β cells.
    
  